FATE

FATE THERAPEUTICS INC

FATE·31189P102·US·Common Stock·Healthcare - Biotechnology-Activist

FATE (FATE THERAPEUTICS INC) is held by 82 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($19.7M), VANGUARD PORTFOLIO MANAGEMENT LLC ($12.3M), VANGUARD CAPITAL MANAGEMENT LLC ($12M). Net institutional sentiment: Mixed.

82
Holders
(6 Elite)
$123.7M
Total Value
54% (96)
Consensus
52 buying - 44 selling
13F: Insider & Congress: Updated regularly
FATE

Smart Money Verdict

View all
Loading verdict
Held by 82 funds
6 elite

Who's Trading

Source dates: Price Oct 12, 2026 · Insiders Aug 5, 2026 · Activists Jul 8, 2026 · Congress none

InsiderTCTAHL CINDYSell $95KAug 4, 2026
InsiderVBValamehr BahramSell $108KAug 4, 2026
ActivistBlackRock, Inc.BlackRock, Inc.1.9%Jul 8, 2026
Checking access…

Top Holders

Checking access…
Action
Decreased
7.3M(-27.5%)$19.7M0.0%+32.04%
0
Increased
4.5M(+9.9%)$12.3M0.0%+42.92%
31
Increased
4.4M(+6.0%)$12M0.0%+47.32%
30
Increased
3.8M(+27.8%)$10.4M0.0%+36.29%
35
Increased
3.6M(+3.5%)$9.7M0.0%+42.74%
29
Increased
3M(+0.3%)$8.1M0.0%+97.86%
27
New
2.4M$6.6M0.0%-21.11%
38
Increased
2M(+54.3%)$5.5M0.0%-64.10%
38
Decreased
1.3M(-49.0%)$3.6M0.0%-89.25%
0
Increased
1M(+58.7%)$2.8M0.0%+24.23%
38
Increased
993,308(+5.3%)$2.7M0.0%-63.40%
28
Decreased
694,580(-9.5%)$1.9M0.0%-31.33%
0
Decreased
640,428(-2.0%)$1.7M0.0%+55.47%
0
Decreased
610,949(-19.2%)$1.6M0.0%-90.14%
0
Decreased
590,178(-67.6%)$1.6M0.0%+41.92%
0
New
578,150$1.6M0.0%-21.11%
35
Increased
574,995(+22.4%)$1.6M0.0%+38.50%
31
Decreased
558,928(-75.3%)$1.5M0.0%-72.38%
0
Increased
511,050(+71.2%)$1.4M0.0%+1.69%
38
New
492,426$1.3M0.0%-21.11%
35

Showing 1-20 of 102

1 / 6
FATEFATEFATE THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used